Hypertension and the kidney:  implications of the kidney for effective antihypertensive therapy
Hollenberg
N K
NK
Departments of Medicine and Radiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D009248:Nadolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012079:Renal Circulation; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D009248:Nadolol; D011433:Propranolol